Quest Diagnostics
DGX
#1089
Rank
ยฃ13.64 B
Marketcap
ยฃ122.26
Share price
1.86%
Change (1 day)
14.07%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Net assets

Net assets on the balance sheet as of September 2024 : ยฃ5.44 Billion

According to Quest Diagnostics 's latest financial reports the company has ยฃ5.44 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Quest Diagnostics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$ยฃ5.03 B1.46%
2022-12-31$ยฃ4.96 B2.14%
2021-12-31$ยฃ4.86 B-3.84%
2020-12-31$ยฃ5.05 B15.03%
2019-12-31$ยฃ4.39 B4.39%
2018-12-31$ยฃ4.21 B13.01%
2017-12-31$ยฃ3.72 B-2.96%
2016-12-31$ยฃ3.83 B18.94%
2015-12-31$ยฃ3.22 B16.05%
2014-12-31$ยฃ2.78 B15.47%
2013-12-31$ยฃ2.40 B-7%
2012-12-31$ยฃ2.58 B8.36%
2011-12-31$ยฃ2.39 B-8.99%
2010-12-31$ยฃ2.62 B5.94%
2009-12-31$ยฃ2.47 B0.78%
2008-12-31$ยฃ2.45 B46.99%
2007-12-31$ยฃ1.67 B8.56%
2006-12-31$ยฃ1.54 B-3.8%
2005-12-31$ยฃ1.60 B34.4%
2004-12-31$ยฃ1.19 B-10.95%
2003-12-31$ยฃ1.33 B21.35%
2002-12-31$ยฃ1.10 B19.73%
2001-12-31$ยฃ0.92 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
ยฃ6.43 B 18.27%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ4.28 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.71 B-86.88%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ44.12 M-99.19%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.77 B-49.00%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands